½ÃÀ庸°í¼­
»óǰÄÚµå
1402731

Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¿¹Ãø(-2030³â) : Áö¿ªº° ºÐ¼® - Á¦Ç°º°, ½Ã¼úº°, ÃÖÁ¾»ç¿ëÀÚº°

South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Forecast to 2030 - Regional Analysis - Product (Dental Bone Graft Substitute and Dental Barrier Membrane), Procedures, and End User (Hospitals, Dental Clinics, and Others)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 94 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº 2022³â 4,116¸¸ ´Þ·¯¿¡¼­ 2030³â 7,976¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ±â¾÷µéÀÇ Àü·«Àû °³¹ß

Á¦Ç° Ãâ½Ã, M&A, »ç¾÷ È®Àå°ú °°Àº ½ÅÈï±¹ ½ÃÀåÀÌ Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. Graft PlugÀÇ Ãâ½Ã¸¦ ¹ßÇ¥ÇÏ¸ç ¹ßÄ¡ºÎ ¹× Ä¡ÁÖ °á¼Õ ºÎÀ§ ÃæÀüÀ» À§ÇÑ »ýüÀç·á Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇß½À´Ï´Ù. 2023³â 5¿ù, ½ºÆ®¶ó¿ì¸¸Àº ½ºÀ§½º ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ GalvoSurge Dental AG¸¦ ÀμöÇß½À´Ï´Ù. 2022³â 10¿ù¿¡´Â »À, ¿¬°ñ, Á¶Á÷ Àç»ý Àü¹® ±â¾÷ °¡À̽ºÆ®¸®È÷°¡ ¹Ì±¹ ¸°Ä¡ ¹ÙÀÌ¿À·ÎÁ÷½º(Lynch Biologics)¸¦ ÀμöÇØ ÀÓÇöõÆ® ÁÖº¯¿° Ä¡·á¸¦ Áö¿øÇÏ´Â ÀÓÇöõÆ® °ü¸® ¹× À¯Áöº¸¼ö ¼Ö·ç¼ÇÀ» Àü¹®À¸·Î ÇÕ´Ï´Ù. À̹ø Àμö·Î °¡À̽ºÆ®¸®È÷ ÆÄ¸¶´Â ¸°Ä¡ ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ ÁÖ¿ä Á¦Ç°ÀÎ GEM 21S(GEM 21S´Â °ñ Çü¼º ¹× »óó Ä¡À¯¸¦ ÃËÁøÇÏ´Â ¼ºÀå ÀÎÀÚ¸¦ ±â¹ÝÀ¸·Î ÇÏ´Â Á¦Ç°)¸¦ Æ÷Æ®Æú¸®¿À¿¡ Ãß°¡ÇÏ¿© Æ÷Æ®Æú¸®¿À¸¦ °­È­Çß½À´Ï´Ù. ¾ç»ç´Â ¶ÇÇÑ Ä¡°ú Àç»ý ±â¼ú Çõ½ÅÀ» À§ÇØ 2022³â 12¿ù Ä¡°ú¿ë ÀÓÇöõÆ® Ä¡·á Á¦Ç°À» ¼³°è, Á¦Á¶ ¹× ÆÇ¸ÅÇÏ´Â ³×¿À½º ±×·ìÀÌ ºÏÀ¯·´ Áö¿ª¿¡ »õ·Î¿î ¿µ¾÷ °ÅÁ¡À» °³¼³Çß½À´Ï´Ù. ÀÌ ½Ã¼³Àº Ä¡°ú ÀÇ·áÁø°ú ȯÀÚ¸¦ Áö¿øÇϱâ À§ÇØ 2022³â 12¿ù 1ÀÏ ºÏÀ¯·´ Áö¿ª¿¡¼­ ¿µ¾÷À» ½ÃÀÛÇßÀ¸¸ç, 2021³â 1¿ù µ§Ã÷ÇöóÀÌ ½Ã·Î³ª´Â Çõ½ÅÀûÀÎ OSSIX Àç»ý ¼Ö·ç¼ÇÀÇ ¼±µµÀûÀÎ °ø±Þ¾÷üÀÎ Datum DentalÀ» ÀμöÇß½À´Ï´Ù. À̹ø Àμö·Î µ§Ã÷ÇöóÀÌ ½Ç·Î³ª´Â ´ÙÅù µ§Å»ÀÇ °­·ÂÇÑ OSSIX ¹ÙÀÌ¿À¼ÒÀç Æ÷Æ®Æú¸®¿À¸¦ È®º¸ÇÒ ¼ö ÀÖ°Ô µÆ½À´Ï´Ù. ¶ÇÇÑ, ±Û¸®¸ÅÆ®¸¯½º´Â ÀÎüÀÇ ÀÚ¿¬ÀûÀÎ Äݶó°Õ »çÀÌŬ, Áï ´çÈ­¶ó´Â »ýÈ­ÇÐÀû °úÁ¤À» ¸ð¹æÇÑ ±Û¸®¸ÅÆ®¸¯½º(GLYMATRIX)¸¦ ÅëÇØ À¯µµÇÏ »À Àç»ý ¹× À¯µµÇÏ Á¶Á÷ Àç»ýÀ» À§ÇÑ OSSIX Á¦Ç°ÀÇ ±âÃʸ¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå °³¿ä

Áß³²¹Ì ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ Áß³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀåÀº Ä¡°ú ÁúȯÀÇ Áõ°¡, Ä¡°ú °ü±¤ÀÇ Áõ°¡, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¾öû³­ ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¸ÅÃâ ¹× 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)

Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¼¼ºÐÈ­

Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Á¦Ç°, ½Ã¼ú, ÃÖÁ¾»ç¿ëÀÚ ¹× ±¹°¡º°·Î ¼¼ºÐÈ­µË´Ï´Ù.

Á¦Ç°À» ±âÁØÀ¸·Î Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°°ú Ä¡°ú¿ë ¹è¸®¾î ¸âºê·¹ÀÎÀ¸·Î ±¸ºÐµÇ¸ç, 2022³â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ºÎ¹®ÀÌ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Ä¡·á¹ýÀ» ±âÁØÀ¸·Î Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº °¡À̵å ÇÏ °ñÀç»ý(GBR) Ä¡·á, °¡À̵å ÇÏ Á¶Á÷ Àç»ý(GTR) Ä¡·á, »çÀ̳ʽº ¸®ÇÁÆ® ¹× ¸´Áö ½ºÇø´ Ä¡·á, Ä¡Á¶°ñ À¶±â º¸Á¸(ARP), ºí·Ï À̽Ä, Ä¡ÁÖ Àç»ý, ¼ÒÄÏ º¸Á¸, ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2022³â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº »çÀ̳ʽº ¸®ÇÁÆ® ¹× ¸´Áö ½ºÇø´ ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº º´¿ø, Ä¡°ú Áø·á¼Ò ¹× ±âŸ·Î ºÐ·ùµÇ¸ç, Ä¡°ú Áø·á¼Ò ºÎ¹®Àº 2022³â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î´Â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ±âŸ ³²¹Ì´Â 2022³â Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀåÀ» Áö¹èÇß½À´Ï´Ù.

Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Institut Straumann AG´Â Áß³²¹Ì Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷µé Áß ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå »óȲ

  • PEST ºÐ¼®
    • Áß³²¹ÌÀÇ PEST ºÐ¼®

Á¦5Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Ä¡ÁÖÁúȯ°ú ±¸°­¾Ï ºÎ´ã Áõ°¡
    • ½ÃÀå ±â¾÷ÀÇ Àü·«Àû °³Ã´
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç°°ú ½Ã¼úÀÇ °íºñ¿ë°ú Ä¡°ú °ËÁø Áö¿¬
  • ½ÃÀå ±âȸ
    • Ä¡°úÀÇ·áÀÇ ±â¼ú °³¹ß
  • ÇâÈÄ µ¿Çâ
    • CAD/CAM ±â¼ú¿¡ ÀÇÇÑ Ä¡°úÀÇ·á µðÁöÅÐÈ­
  • ¿µÇ⠺м®

Á¦6Àå Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : Áß³²¹Ì ½ÃÀå ºÐ¼®

  • Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¸ÅÃâ, 2022-2030³â

Á¦7Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå - 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : Á¦Ç°º°

  • Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹°
  • Ä¡°ú¿ë ¹è¸®¾î ¸âºê·¹ÀÎ

Á¦8Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå - ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : ½Ã¼úº°

  • °ñÀ¯µµÀç»ý ½Ã¼ú(GBR)
  • Á¶Á÷À¯µµÀç»ý ½Ã¼ú(GTR)
  • »çÀ̳ʽº ¸®ÇÁÆ® ½Ã¼ú ¹× ¸´Áö ½ºÇø´ ½Ã¼ú
  • Ä¡Á¶Á¦ º¸Á¸¼ú(ARP)
  • ºí·Ï ±×·¡ÇÁÆ® ½Ã¼ú
  • Ä¡ÁÖ Àç»ý ½Ã¼ú
  • ¹ßÄ¡¿Í º¸Á¸¼ú
  • ±âŸ

Á¦9Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå - ¸ÅÃâ°ú 2030³â±îÁö ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Ä¡°úÀÇ¿ø
  • ±âŸ

Á¦10Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ±¹°¡º° ºÐ¼®

Á¦11Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¾÷°è »óȲ

  • Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå ¼ºÀå Àü·«
  • À¯±âÀû Àü°³
  • ¹«±âÀû Àü°³

Á¦12Àå Áß³²¹ÌÀÇ Ä¡°ú¿ë °ñÀÌ½Ä ´ëü¹° ¹× ¹è¸®¾î ¸âºê·¹ÀÎ ½ÃÀå : ÁÖ¿ä ±â¾÷ °³¿ä

  • Geistlich Pharma AG
  • Medtronic Plc
  • Dentsply Sirona Inc
  • ZimVie Inc
  • Regenity Biosciences Inc
  • Institut Straumann AG

Á¦13Àå ºÎ·Ï

ksm 24.01.15

The South & Central America dental bone graft substitute and barrier membrane market is expected to grow from US$ 41.16 million in 2022 to US$ 79.76 million by 2030. It is estimated to grow at a CAGR of 8.6% from 2022 to 2030.

Strategic Developments by Market Players Fuel South & Central America Dental Bone Graft Substitute and Barrier Membrane Market

Development strategies such as product launches, mergers and acquisitions, and expansions boost the growth of the South & Central America Dental Bone Graft Substitute and Barrier Membrane Market. In April 2023, ZimVie announced the launch of RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, which helped it extend its portfolio of biomaterials that are intended for filling extraction sockets and periodontal defects. The products are commercially available in North America. In May 2023, Straumann acquired GalvoSurge Dental AG, a Swiss medical device manufacturer. The acquired company specializes in implant care and maintenance solutions to support the treatment of peri-implantitis. In October 2022, Geistlich, specialized in the regeneration of bone, cartilage, and tissue, acquired Lynch Biologics, US. The acquisition helped Geistlich Pharma to strengthen its portfolio by adding Lynch Biologics, LLC's leading GEM 21S product to it. GEM 21S is based on a growth factor that accelerates bone formation and wound healing. The companies further aim to innovate regenerative technologies in dentistry. In December 2022, Neoss Group, which designs, manufactures, and sells dental implant treatment products, opened a new sales office in the Nordic region. The facility commenced operations in the Nordic region on December 01, 2022, to support dental professionals and their patients. In January 2021, Dentsply Sirona acquired Datum Dental, a leading provider of innovative OSSIX regenerative solutions. The acquisition enabled Dentsply Sirona to acquire the strong OSSIX biomaterial portfolio of Datum Dental, Ltd. It also offered it access to the patented GLYMATRIX technology of Datum Dental Ltd. GLYMATRIX mimics the natural collagen cycle in the body, i.e., a biochemical process called glycation. GLYMATRIX forms the basis of OSSIX products for guided bone regeneration, as well as guided tissue regeneration.

South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Overview

The South & Central America market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in this region has immense potential for growth owing to factors such as increasing cases of dental diseases, growing dental tourism, and the presence of major market players.

South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Segmentation

The South & Central America dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user and country.

Based on product, the South & Central America dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the South & Central America dental bone graft substitute and barrier membrane market in 2022.

Based on procedures, the South & Central America dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the South & Central America dental bone graft substitute and barrier membrane market in 2022.

Based on end user, the South & Central America dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the South & Central America dental bone graft substitute and barrier membrane market in 2022.

Based on country, the South & Central America dental bone graft substitute and barrier membrane market is segmented into Brazil, Argentina and the Rest of South and Central America. The Rest of South and Central America dominated the South & Central America dental bone graft substitute and barrier membrane market in 2022.

Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, and Institut Straumann AG are some of the leading companies operating in the South & Central America dental bone graft substitute and barrier membrane market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America dental bone graft substitute and barrier membrane market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America dental bone graft substitute and barrier membrane market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis

5. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Burden of Periodontal Diseases and Oral Cancer
    • 5.1.2 Strategic Developments by Market Players
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Products & Procedures and Delays in Dental Check-ups
  • 5.3 Market Opportunities
    • 5.3.1 Technological Developments in Dentistry
  • 5.4 Future Trends
    • 5.4.1 Digitization of Dentistry with CAD/CAM Technology
  • 5.5 Impact Analysis:

6. Dental Bone Graft Substitute and Barrier Membrane Market - South & Central America Market Analysis

  • 6.1 South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Dental Bone Graft Substitute
    • 7.3.1 Overview
    • 7.3.2 Dental Bone Graft Substitute: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Allograft
      • 7.3.3.1 Overview
      • 7.3.3.2 Allograft: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Xenograft
      • 7.3.4.1 Overview
      • 7.3.4.2 Xenograft: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Synthetic Bone Graft
      • 7.3.5.1 Overview
      • 7.3.5.2 Synthetic Bone Graft: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Autografts
      • 7.3.6.1 Overview
      • 7.3.6.2 Autografts: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.7 Alloplasts
      • 7.3.7.1 Overview
      • 7.3.7.2 Alloplasts: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.8 Demineralized Bone Matrix (DBM)- Allograft
      • 7.3.8.1 Overview
      • 7.3.8.2 Demineralized Bone Matrix (DBM)- Allograft: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.9 Others
      • 7.3.9.1 Overview
      • 7.3.9.2 Others: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Dental Barrier Membrane
    • 7.4.1 Overview
    • 7.4.2 Dental Barrier Membrane: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 Resorbable Membrane
      • 7.4.3.1 Overview
      • 7.4.3.2 Resorbable Membrane: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Non-Resorbable Membrane
      • 7.4.4.1 Overview
      • 7.4.4.2 Non-Resorbable Membrane: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Procedures

  • 8.1 Overview
  • 8.2 South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by Procedures 2022 & 2030 (%)
  • 8.3 Guided Bone Regeneration Procedures (GBR)
    • 8.3.1 Overview
    • 8.3.2 Guided Bone Regeneration Procedures (GBR): South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Guided Tissue Regeneration Procedures (GTR)
    • 8.4.1 Overview
    • 8.4.2 Guided Tissue Regeneration Procedures (GTR): South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Sinus-lift Procedures and Ridge-split Procedures
    • 8.5.1 Overview
    • 8.5.2 Sinus-lift Procedures and Ridge-split Procedures: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Alveolar Ridge Preservation (ARP)
    • 8.6.1 Overview
    • 8.6.2 Alveolar Ridge Preservation (ARP): South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Block-graft Procedures
    • 8.7.1 Overview
    • 8.7.2 Block-graft Procedures: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Periodontal Regeneration Procedures
    • 8.8.1 Overview
    • 8.8.2 Periodontal Regeneration Procedures: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Socket Preservation
    • 8.9.1 Overview
    • 8.9.2 Socket Preservation: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Dental Clinics
    • 9.4.1 Overview
    • 9.4.2 Dental Clinics: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market - Country Analysis

  • 10.1 South & Central America Dental Bone Graft Substitute and Barrier Membrane Market, Revenue And Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 South & Central America Dental Bone Graft Substitute and Barrier Membrane Market by Country
      • 10.1.1.2 Brazil
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Brazil Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2.1 Brazil Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.2.2.2 Brazil Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.2.3 Brazil Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.2.4 Brazil Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.2.5 Brazil Dental Bone Graft Substitute and Barrier Membrane Market, by End User
      • 10.1.1.3 Argentina
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Argentina Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Argentina Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.3.3.1 Argentina Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.3.3.2 Argentina Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.3.4 Argentina Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.3.5 Argentina Dental Bone Graft Substitute and Barrier Membrane Market, by End User
      • 10.1.1.4 Rest of South & Central America
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Rest of South & Central America Dental Bone Graft Substitute and Barrier Membrane Market, by Product
        • 10.1.1.4.3.1 Rest of South & Central America Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Bone Graft Substitute
        • 10.1.1.4.3.2 Rest of South & Central America Dental Bone Graft Substitute and Barrier Membrane Market, by Dental Barrier Membrane
        • 10.1.1.4.4 Rest of South & Central America Dental Bone Graft Substitute and Barrier Membrane Market, by Procedures
        • 10.1.1.4.5 Rest of South & Central America Dental Bone Graft Substitute and Barrier Membrane Market, by End User

11. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in South & Central America Dental Bone Graft Substitute and Barrier Membrane Market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. South & Central America Dental Bone Graft Substitute and Barrier Membrane Market, Key Company Profiles

  • 12.1 Geistlich Pharma AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Dentsply Sirona Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 ZimVie Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Regenity Biosciences Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Institut Straumann AG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦